An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation

NCT01571583 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C Virus (HCV) Infection

Interventions

DRUG: Telaprevir
DRUG: Pegylated interferon alfa-2a
DRUG: Ribavirin

Sponsor

Janssen-Cilag International NV